logo
Select company
Select metric
77.86%Cash to Assets Ratio
VS
Market
96
Sector
87
Industry
80
History
73
$ 5.62Close
$ 3.81 - $ 9.02 52-Week Range
Ticker Information

Ticker

DTIL

Company Name

PRECISION BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PRECISION BIOSCIENCES INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DTIL - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 108.93M$ 84.81M77.86%
3/31/2025$ 124.41M$ 99.79M80.21%
12/31/2024$ 136.39M$ 108.47M79.53%
9/30/2024$ 153.26M$ 121.33M79.17%
6/30/2024$ 165.8M$ 123.57M74.53%
3/31/2024$ 184.74M$ 137.77M74.57%
12/31/2023$ 159.78M$ 116.68M73.02%
9/30/2023$ 164.34M$ 122.23M74.38%
6/30/2023$ 181.7M$ 137.79M75.84%
3/31/2023$ 204.5M$ 158.13M77.33%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PRECISION BIOSCIENCES INC's latest trailing twelve months (TTM) Cash to Assets stands at 61.74%.
  • Over the past 5 years, PRECISION BIOSCIENCES INC's average Cash to Assets has been 72.98%.
  • The median Cash to Assets for PRECISION BIOSCIENCES INC during this period was 74.55%
  • PRECISION BIOSCIENCES INC reached its highest Cash to Assets over the past 5 years at 80.21%.
  • The lowest Cash to Assets recorded by PRECISION BIOSCIENCES INC in the same timeframe 59.8%

PRECISION BIOSCIENCES INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
ADVM : ADVERUM BIOTECHNOLOGIES INC 46.16%RANI : RANI THERAPEUTICS HOLDINGS INC 60.46%PLUR : PLURI INC 16.33%IGC : IGC PHARMA INC 8.38%CLSD : CLEARSIDE BIOMEDICAL INC 61.15%RNXT : RENOVORX INC 90.26%LSTA : LISATA THERAPEUTICS INC 66.91%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC 15.63%COEP : COEPTIS THERAPEUTICS HOLDINGS INC 16.38%SER : SERINA THERAPEUTICS INC 67.57%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for PRECISION BIOSCIENCES INC is calculated as follows: CashnEq [ $ 104.15M ] / Assets [ $ 168.69M ]
(=) Cash to Assets [ 61.74% ]

DTIL - Cash to Assets Ratio, Last 5 years

59.8%

Minimum

Dec 31, 2020

80.21%

Maximum

Mar 31, 2025

72.98%

Average

74.55%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.76% with a standard deviation of 9.51%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.71%
average9.76%
median6.41%
std9.51%